NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (AMEX:NBS), the first company to specialize in the collection, processing and long term storage of stem cells from healthy adults for personal use in times of critical medical need, today announced completion of its second closing of its public offering generating $1 million in gross proceeds. Together with the gross proceeds of the first closing of the public offering on August 9, 2007, the Company has raised an aggregate of approximately $6.3 million.
